Search

everythinglearnresearchcommunity

for

Search:↓

Notopterygii rhizoma et radix (Qiang Huo) can effectively treat psoriasis by reducing skin symptoms and inflammation.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

Growth hormone-releasing hormone (GHRH) boosts hair growth and human scalp hair follicles have their own growth hormone system.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

The new microneedle system promotes hair growth by improving the hair follicle environment.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

5α-reduced neurosteroids may help regulate glial cell differentiation.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

The RHC complex with nicotinamide promotes hair growth and health.

Eplerenone, a mineralocorticoid receptor antagonist, was found to promote hair growth in human hair follicles.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Thyroid receptor β can help develop new drugs to treat hair loss.

Hydralazine and minoxidil are blood pressure medications that relax blood vessels, with potential side effects like rapid heartbeat and fluid retention, and are used for severe or pregnancy-related hypertension.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Ginsenoside Rb1 slows down aging in mice by affecting cell growth, cell death, and metabolism.

Growth hormone therapy can improve symptoms and growth in children with Vitamin-D Dependent Rickets Type-2.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Ginsenoside Re from ginseng may help hair grow by blocking a specific growth-inhibiting pathway.

GLP-1 agonists may help treat certain skin conditions.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.